Overview * SolarEdge ( SEDG ) Q3 revenue grows 18% qtr/qtr, beating analyst expectations * Adjusted loss per share beats analyst estimates, reflecting improved financial performance * Company reports reduced net loss and operating expenses qtr/qtr Outlook * Company expects Q4 2025 revenue between $310 mln and $340 mln * Non-GAAP gross margin for Q4 2025 expected between 19% and...

Overview * Smith Douglas Q3 home closing revenue falls 6% yr/yr, with gross margin declining to 21% * Net new home orders rise 15% in Q3, showing growth in demand * Active community count up 32% to 98, reflecting expansion efforts Outlook * Company did not provide specific financial guidance for future quarters Result Drivers * EXPANSION EFFORTS - Co...

Overview * Larimar reports Q3 net loss of $47.7 mln, driven by increased R&D expenses * Company modifies nomlabofusp dosing to reduce anaphylaxis risk * BLA submission for nomlabofusp targeted for Q2 2026 Outlook * Larimar targets BLA submission for nomlabofusp in Q2 2026 * Company plans U.S. launch of nomlabofusp in early 2027 * Larimar implementing modified dosing regimen...

Overview * Arvinas ( ARVN ) Q3 revenue drops significantly year-over-year, impacted by completed Novartis agreements * Net loss for Q3 narrows compared to last year * R&D expenses decrease due to lower external and personnel costs Outlook * Arvinas ( ARVN ) plans to initiate a Phase 1b trial for ARV-102 in PSP patients in 1H 2026 * Company...